These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 1696993)

  • 1. CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Smith HR; Olson RR
    J Rheumatol; 1990 Jun; 17(6):833-5. PubMed ID: 1696993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
    Ebo D; DeClerck LS; Bridts CH; Stevens WJ
    In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased peripheral blood B-cells expressing the CD5 molecules in association to autoantibodies in patients with lupus erythematosus and evidence to selectively down-modulate them.
    Böhm I
    Biomed Pharmacother; 2004 Jun; 58(5):338-43. PubMed ID: 15194170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD5 positive B lymphocytes in seronegative juvenile arthritis.
    Martini A; Massa M; De Benedetti F; Viola S; Neirotti G; Burgio RG
    J Rheumatol; 1990 Jul; 17(7):932-5. PubMed ID: 1698986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseases.
    Markeljević J; Batinić D; Uzarević B; Bozikov J; Cikes N; Babić-Naglić D; Horvat Z; Marusić M
    J Rheumatol; 1994 Dec; 21(12):2225-30. PubMed ID: 7535356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity antibodies to ssDNA are produced by CD-B cells in systemic lupus erythematosus patients.
    Casali P; Burastero SE; Balow JE; Notkins AL
    J Immunol; 1989 Dec; 143(11):3476-83. PubMed ID: 2479680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.
    Winchester RJ; Winfield JB; Siegal F; Wernet P; Bentwich Z; Kunkel HG
    J Clin Invest; 1974 Nov; 54(5):1082-92. PubMed ID: 4138924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R; Albert D
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
    Henneken M; Dörner T; Burmester GR; Berek C
    Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human blood L lymphocytes in patients with active systemic lupus erythematosus, rheumatoid arthritis and scleroderma: a comparison with T and B cells.
    Horwitz DA; Juul-Nielsen K
    Clin Exp Immunol; 1977 Dec; 30(3):370-8. PubMed ID: 304786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human CD5 (Leu-1, OKT1)+ B lymphocytes and the antibodies they produce.
    Burastero SE; Casali P
    Contrib Microbiol Immunol; 1989; 11():231-62. PubMed ID: 2479500
    [No Abstract]   [Full Text] [Related]  

  • 12. CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B.
    Hagn M; Ebel V; Sontheimer K; Schwesinger E; Lunov O; Beyer T; Fabricius D; Barth TF; Viardot A; Stilgenbauer S; Hepp J; Scharffetter-Kochanek K; Simmet T; Jahrsdörfer B
    Eur J Immunol; 2010 Jul; 40(7):2060-9. PubMed ID: 20394077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell depletion therapy in systemic rheumatic diseases: different strokes for different folks?
    Stohl W; Looney RJ
    Clin Immunol; 2006 Oct; 121(1):1-12. PubMed ID: 16697258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphologic and immunomorphologic studies in rheumatoid arthritis and systemic lupus erythematosus].
    Wagner T
    Patol Pol; 1984; 35(1):45-64. PubMed ID: 6333663
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoglobulins on the surface of lymphocytes in autoimmune disease. II. Lymphocytotoxins on the surface of lymphocytes.
    Gergely P; Szegedi G; Stenszky E; Fekete B; Szabó G; Petrányi G
    Acta Med Acad Sci Hung; 1974; 31(1-2):115-8. PubMed ID: 4549467
    [No Abstract]   [Full Text] [Related]  

  • 16. Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes.
    Casali P; Notkins AL
    Annu Rev Immunol; 1989; 7():513-35. PubMed ID: 2469441
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of circulating immunoblasts in the peripheral blood of patients with systemic lupus erythematosus and other rheumatic diseases].
    Bulanova TD; le Go A; Alekberova ZS; Polianskaia IP
    Ter Arkh; 1980; 52(6):64-7. PubMed ID: 6967635
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoglobulins on the surface of lymphocytes in autoimmune diseases.
    Gergely P; Szegedi G; Szabó G; Fekete B; Petrányi G
    Acta Med Acad Sci Hung; 1973; 30(3):227-9. PubMed ID: 4594738
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell surface antigen CD5 is a marker for activated human B cells.
    Werner-Favre C; Vischer TL; Wohlwend D; Zubler RH
    Eur J Immunol; 1989 Jul; 19(7):1209-13. PubMed ID: 2474446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible different mechanisms of B cell activation in systemic lupus erythematosus and rheumatoid arthritis: opposite expression of low-affinity receptors for IgE (CD23) on their peripheral B cells.
    Kumagai S; Ishida H; Iwai K; Tsubata T; Umehara H; Ozaki S; Suginoshita T; Araya S; Imura H
    Clin Exp Immunol; 1989 Dec; 78(3):348-53. PubMed ID: 2532990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.